News

Bayer HealthCare’s Mark 7 Arterion angiographic contrast injector

There have been several recent advances with contrast media injector technology, including cutting costs by reducing contrast waste and automated data collection for the dose a patient receives....

peripheral arterial disease, Atherectomy devices, ISET

Ensuring that patients with peripheral arterial disease (PAD) get tested and treated with minimally invasive endovascular therapy saves legs and lives suggests a study in which amputation rates...

Medtronic, In.Pact Admiral DCB, PAD, U.S. launch, drug-coated balloon

United States hospitals began using a new medical device from Medtronic plc  called the In.Pact Admiral drug-coated balloon (DCB) to treat patients with peripheral arterial disease (PAD) in...

ISET, aneurysms, blood flow, software, flow diverter, FFR catheters

A new computer program allows doctors to assess blood flow as they are using flow-diverter devices to treat life-threatening aneurysms, suggests a preliminary study being presented at the 27th...

ASCERT, coronary bypass graft surgery, angioplasty, quality of life, value

Coronary bypass graft surgery commonly used to treat patients with coronary heart disease results in improved quality of life but also costs more than another often-used less invasive technique,...

Cath lab

In his lecture, Harrington will argue that simplification of larger trials, better early-phase investigations and the use of electronic health records can ease the path to new research.

Stents, BioMimics 3D, Veryan Medical, Biosensors International Group

Biosensors International Group has announced a distribution agreement with Veryan Medical Ltd. for BioMimics 3D, a nitinol stent with three-dimensional helical geometry designed for use in the...

drug-eluting balloons, DEB, ECRI, report, peripheral artery disease, PAD, cath

ECRI Institute has created a report that offers an overview of drug-eluting balloon (DEB) technology, “Health Technology Forecast report, "Drug-eluting Angioplasty Balloons for...

Artificial Heart, Ventricular Assist Device, Heart failure, SynCardia

SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct a clinical study of the effectiveness of the SynCardia temporary Total Artificial Heart for...

CardioKinetix, Parachute, Heart failure

There are several new interventional and minimally invasive surgical heart failure (HF) devices in development or in trials that might offer new ways to boost patient volume in the coming years....

Neovasc Inc. has commenced a public offering in the United States of 8 million shares of the company to raise money for upcoming U.S. clinical trials and development of its transcatheter mitral...

Balloon catheters, Heart Valve repair, Cath Lab, Hybrid OR

Maquet Medical Systems USA announced an agreement to serve as the exclusive U.S. distributor of InterValve Inc.'s V8 Aortic Valvuloplasty Balloon Catheter.

Thoratec, HeartMate III, VAD, NewYork Presbyterian, trial, ventricular assist

NewYork-Presbyterian Hospital/Columbia University Medical Center is one of a select group of medical centers participating in a clinical trial of a new device for advanced heart failure patients,...

ECRI Institute has released an updated comparison on cardiac resuscitators used during cardiopulmonary resuscitation (CPR).

FEops, TAVIguide, Series A financing, navigation, advanced visualization

FEops announced the closing of a €1.3 million (~$1.9 million USD) series A financing round, led by Capricorn Venture Partners and PMV. The funding will be used to support the launch of FEops’...

antiplatelet therapy, pharmaceuticals, cath lab, clinical trial, ticagrelor

AstraZeneca announced that the PEGASUS-TIMI 54 study, a large-scale outcomes trial involving more than 21,000...

The number of IVC filters placed has more than doubled in the last 10 years, and by some estimates, less than half of these retrievable devices are actually removed each year.

Bellerophon Therapeutics LLC announced that it has completed enrollment of its PRESERVATION I clinical trial of Bioabsorbable Cardiac Matrix (BCM), an investigational implantable medical device...

Clinical trial, MRI system, Peripheral Artery Disease, Renal Artery Stenosis

Non-contrast enhanced MR angiography (MRA) techniques have attracted interest in the medical community for diagnosing renal artery stenosis, as it eliminates the need for contrast agents used with...

The Society of Interventional Radiology (SIR) unveiled a new brand for the society and its research organization, the SIR Foundation.